Dysphagia and Dysphonia Outcomes in SARS CoV-2 (COVID-19) Infection (DYADS Study)

NHS Foundation Trust

Status: Unknown

Conditions: SARS (Severe Acute Respiratory Syndrome); Voice Disorders; Subglottic Stenosis; Dysphagia; Quality of Life; SARS-CoV-2 Infection; Covid19; Swallowing Disorder; Dysphonia; SARS Pneumonia

Treatments: Diagnostic Test: Videofluoroscopy; Diagnostic Test: Fibreoptic Endoscopic Evaluation of Swallowing (FEES); Other: Voice Symptom Scale (VoiSS); Other: Dysphagia Handicap Index (DHI)

Study type: Observational

Funder types: Other

Identifiers

NCT04584658

20/NW/0333

Details and patient eligibility

About

This study examines the presence, severity and natural history of dysphagia and dysphonia in the post-extubation and severely unwell COVID-19 patient.

Enrollment: 36 estimated patients

Sex: All

Ages: 18 to 85 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who have been diagnosed with a positive SARS CoV-2 test.
• Patients who have been diagnosed with dysphonia and/or dysphagia following COVID 19 treatment.
• Patients who require investigation and management for dysphonia and/or dysphagia following COVID 19 treatment.
• Adult patients aged 18 years - 85 years.
• Patients that meet threshold for referral to the joint MDT clinic following screening

Exclusion criteria

• Patients who cannot undertake the assessment for dysphonia and/or dysphagia.
• Patients who are being managed with palliative intent.
• Patients with pre-existing dysphonia and/or dysphagia not previously responding to therapy (pre-existing prior to COVID-19 diagnosis).